Home reporting in C3G: a study for patients and caregivers
Part of Kidney & urinary clinical trials.
This study uses a smartphone app to track health information from people with C3G (a rare kidney disease) and their caregivers. It aims to collect real-world data to better understand the condition, no matter what treatments you are on.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with C3G (a kidney condition called complement 3 glomerulopathy).
- You are an adult (18 or older) who either has C3G or is caring for an adult or child with C3G.
- You can understand and agree to take part in the study.
- You have a smartphone or tablet to use the study app.
- You live in the United States and can read English.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests an experimental drug called OMS906 for people with C3G or ICGN (immune-related kidney diseases). It aims to see if the drug is safe and can reduce kidney damage. You may qualify if you have a confirmed diagnosis, high protein in your urine, and stable kidney function.
This study tests a smartphone app designed to help people with chronic kidney disease (CKD)—a condition where the kidneys don't filter blood as well as they should—follow the latest medical guidelines. The app aims to make it easier for younger adults to stay on top of their kidney health and treatment.
This study tracks the long-term health of people with C3 glomerulopathy or IC-MPGN, two rare kidney diseases. It does not test a new treatment, but instead collects information from medical records to better understand how these conditions progress over time.
This study tests a phone app (with check-ins on things like blood pressure and weight) to help prevent complications in people with advanced chronic kidney disease. You may be a good match if you’re high risk and can actively measure and share your health data with a kidney care team.
This trial tests whether a smartphone app called MyNutriKidney® can help people with chronic kidney disease (kidney damage that has lasted 3 months or longer) manage their diet better. If you have kidney disease stages 3 to 5 (not yet on dialysis), are 18 or older, and can use the app in English, Malay, or Mandarin, you may be able to join.
This study uses a mobile app to track how IgA nephropathy (IgAN) affects daily life and what treatments people use. It’s open to patients and their caregivers to help researchers learn more about the disease.
Hear when a new C3 Glomerulopathy trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.